- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 1.81M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 1.79M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.74K |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $9.11K |
| Capex | Q1 2026 · Mar 31, 2026 | $650.78K |
| Capex | Q1 2026 · Mar 31, 2025 | $800.17K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.48M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$3.47M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $217.5M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $235.29M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.8M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $6.43M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $9.94M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$46.07M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$49.33M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $144.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $147.22M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $46.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $60.23M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $327.57M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $348.62M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $50.93M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $60.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $281.51M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $299.29M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.77 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$1.50 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.78 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$1.50 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.53M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $4.02M |
| Net Income | Q1 2026 · Mar 31, 2026 | $3.21M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.69M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $7.69M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$302.36K |
| Revenue | Q1 2026 · Mar 31, 2026 | $42.59M |
| Revenue | Q1 2026 · Mar 31, 2025 | $48.91M |